GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

linerixibat   Click here for help

GtoPdb Ligand ID: 14439

Synonyms: compound 56 [PMID: 23678871] | GSK-2330672 | GSK2330672 | Lynavoy®
Approved drug
linerixibat is an approved drug
Compound class: Synthetic organic
Comment: Linerixibat (GSK2330672) is an oral ileal bile acid transporter (IBAT; ASBT; SLC10A2) inhibitor [7].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 4
Rotatable bonds 13
Topological polar surface area 150.41
Molecular weight 546.68
XLogP 2
No. Lipinski's rules broken 2

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCC[C@]1(CC)CS(=O)(=O)C2=CC(=C(C=C2[C@@H](C3=CC=CC=C3)N1)OC)CNC(CC(=O)O)CC(=O)O
Isomeric SMILES CCCC[C@]1(CC)CS(=O)(=O)C2=CC(CNC(CC(=O)O)CC(=O)O)=C(OC)C=C2[C@@H](C3=CC=CC=C3)N1
InChI InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15-26(33)34)23(37-3)16-22(24)27(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2,1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1
InChI Key CZGVOBIGEBDYTP-VSGBNLITSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Selectivity at transporters
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Sodium/bile acid and sulphated solute cotransporter 2 Primary target of this compound Hs Inhibitor Inhibition 7.4 pIC50 - 7
pIC50 7.4 (IC50 4.2x10-8 M) [7]
Description: Determined as inhibition of 3H-taurocholate uptake in HEK293 cells expressing hASBT